REGENXBIO Inc. (NASDAQ:RGNX) Q3 2025 Earnings Call Transcript November 6, 2025
REGENXBIO Inc. beats earnings expectations. Reported EPS is $-1.19834, expectations were $-1.38.
Operator: Welcome, everyone, to the Third Quarter 2025 REGENXBIO Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. At this time, I’d like to turn the conference over to Patrick Christmas, Chief Legal Officer of REGENXBIO. Please go ahead.
Patrick Christmas:...
